Obenshain Andrew

President and CEO, Directorbluebird bio, Inc. (BLUE) · full profile →Form 4 · filed Oct 2, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 30, 2024Sell(S)35K$0.53$18K375K
Sep 30, 2024Grant(A)130K$0410K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-007124) within minutes of acceptance. Every field above traces to the original document. Verify it directly: